HOME >> BIOLOGY >> NEWS
Antiretroviral resistance testing in HIV infected patients improves health and saves costs

During HIV treatment resistance mutations of the virus to antiretroviral drugs may occur and the treatment regimen become less effective. In the present study the authors compared the cost-effectiveness of genotypic antiretroviral resistance testing versus expert opinion for treatment optimization in HIV infected patients with treatment failure. The study is based on data from the Swiss HIV Cohort Study (www.shcs.ch), which is one of the largest cohort studies on HIV disease including patients from all University Clinics and two state hospitals in Switzerland. In this study, both health care costs and productivity costs, i.e. costs due to absence from work because of ill-health, were included in the analysis. Using most recent scientific methods, the authors could show that antiretroviral resistance testing not only increases life expectancy and quality-of-life, but also results in cost savings to society.

"This is the first study that shows that resistance testing not only improves the health of the patients but is also beneficial to the society at large when job productivity changes are considered," said Pedram Sendi, first author and principal investigator, from the Clinic of Infectious Diseases & Hospital Epidemiology of the Basel University Hospital. "We are convinced that our study will be noticed in many countries as it also documents the clinical benefit of antiretroviral resistance testing," comment Manuel Battegay from the Basel University Hospital and Huldrych Gnthard from the Zurich University Hospital, co-principals of this cost-effectiveness study.

In times of increasing pressures to contain health care costs cost-effectiveness analyses are an important source of information to evaluate whether health interventions represent "value for money." This may help to prioritize resource allocation in health care by finding those health technologies that offer the most health outcomes for the resources
'"/>

Contact: Pedram Sendi
pedram.sendi@unibas.ch
41-078-691-8181
Public Library of Science
23-Jan-2007


Page: 1 2

Related biology news :

1. Support for chromosomal theory of cancer found in cancers development of drug resistance
2. 454 sequencing identifies HIV drug resistance at early stage
3. Ultra deep sequencing identifies HIV drug resistance at early stage
4. Cytokine resistance contributes to pathology of type 2 diabetes
5. Largest synthetic gene ever built offers insights into anti-malarial drug resistance
6. WHO data confirms low level of resistance to Tamiflu
7. Unstable leukemia stem cells may predispose patients to drug resistance
8. Gene profiling predicts resistance to breast cancer drug Herceptin
9. IDIBAPS participates in European Network on antibiotic resistances and hospital infections
10. What recognizes what in plant disease resistance?
11. New HIV test may predict drug resistance

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/9/2019)... (PRWEB) , ... March 08, 2019 , ... ... (SITC) is pleased to announce a new initiative focused on women in the ... one-and-a-half day, free program that seeks to celebrate and empower emerging female leaders ...
(Date:3/9/2019)... PRINCETON, N.J. (PRWEB) , ... March 09, 2019 ... ... and highly potent hM3Dq & hM4Di ligands – exciting compounds for scientists studying ... National Institute on Drug Abuse and the National Institute of Neurological Disorders and ...
(Date:3/1/2019)... ... 2019 , ... Geneious would like to announce it is extending the reach ... , Geneious Prime already has a dedicated importer for Vector NTI Advance databases ... will be organised in Geneious in the same way. The next update (expected ...
Breaking Biology News(10 mins):
(Date:3/18/2019)... ... March 18, 2019 , ... For more than 15 years, USDM ... allow life science companies to easily comply with FDA 21 CFR Part 11 and ... a managed service delivering end-to-end GxP compliance from vendor audit through ongoing validation maintenance, ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... announcing that its Canadian partner, the Eye Machine Canada Inc., had been given ... pioneering technology for treating Age-Related Macular Degeneration (AMD). , The previous month, the ...
(Date:3/12/2019)... DENVILLE, N.J. and LIÈGE, Belgium (PRWEB) , ... ... ... for complete solutions for sample preparation and epigenetics research, has launched its third ... the features of the second generation instrument with a user-friendly interface, automated ...
(Date:3/5/2019)... ... March 05, 2019 , ... San Fransisko, or Sisko for ... him at four years old to pursue a career in dressage. According to ... most talented horse that she’d ever worked with. Unfortunately, Sisko suffered an injury ...
Breaking Biology Technology:
Cached News: